Aptamer Solutions Ltd

Related Content

Aptamer and Neuro-Bio collaborate on Alzheimer’s disease diagnostic

Aptamer launches reagent solution for immunohistochemistry

Aptamer partners with BaseCare Therapeutics

Appointment of Interim Chief Commercial Officer, Aptamer Group

Aptamer Group's new deal supports novel therapies

Aptamer opens state-of-the-art laboratories in York, England

Enabling oligonucleotide therapeutics with precision targeting methods

Aptamer Group signs deal with Flip Gene Therapeutics to support the development of inducible gene therapies

Aptamer and Bio-Works collaborate on gene therapy scale up project

Aptamer Group and WuXi AppTec collaborate on Optimer therapeutics

Aptamer partners with pharma company on vaccine development

Aptamer and PinotBio collaborate on drug conjugates

Takeda to evaluate Aptamer Group reagents for drug development

Aptamer Group extends collaboration with AstraZeneca

Aptamer and Cancer Research UK collaborate for drug discovery